Gene · 9180
Papers1,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NF-κB and STAT3 signaling uniquely stratify survival in female glioblastoma patients. | iScience | 2026 | 41716996 | PubTator, text mining | PubMed |
| Cross-Talk between Neurons and Immune Cells in Pruritus: from Mechanisms To Medicines. | Curr Allergy Asthma Rep | 2026 | 41712151 | PubTator, text mining | PubMed |
| Macrophage polarisation under immune regulation as a therapeutic target for tendon-bone healing: multifactorial regulation and mechanistic insights. | Front Immunol | 2026 | 41710885 | PubTator, text mining | PubMed |
| OSMR coordinates a self-perpetuating circuit linking chemoresistance and neutrophil-driven immunosuppression in gastric cancer. | Neoplasia | 2026 | 41653653 | PubTator, text mining | PubMed |
| Molecular architecture of human dermal sleeping nociceptors. | Cell | 2026 | 41643676 | PubTator, text mining | PubMed |
| Association of FADS2 polymorphism rs174538 with fatty acid metabolism and disease severity in Japanese patients with Crohn's disease. | World J Gastroenterol | 2026 | 41551830 | PubTator, text mining | PubMed |
| The multifaceted roles of oncostatin M and its receptor in skin immunity, inflammation, and tumorigenesis. | J Invest Dermatol | 2026 | 41505783 | PubTator, text mining | PubMed |
| Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosis. | bioRxiv | 2026 | 41497665 | PubTator, text mining | PubMed |
| Skeletal muscle methylome-transcriptome disruptions during the onset and progression of colorectal cancer-induced cachexia. | Am J Physiol Cell Physiol | 2026 | 41385570 | PubTator, text mining | PubMed |
| Differential therapeutic implications of the OSM-OSMR signaling pathway in cancer and inflammatory diseases. | Int J Biol Macromol | 2026 | 41338502 | PubTator, text mining | PubMed |
| Structural Model of the Oncostatin M (OSM)-OSMRβ-gp130 Ternary Complex Reveals Pathways of Allosteric Communication in OSM Signaling. | Curr Med Chem | 2026 | 40605163 | PubTator, text mining | PubMed |
| Identification of ferroptosis-related LncRNAs as potential targets for improving immunotherapy in glioblastoma. | Comput Methods Biomech Biomed Engin | 2026 | 39743840 | PubTator, text mining | PubMed |
| Glioblastoma Prognosis and Therapeutic Response Predicted by a Cancer-Associated Fibroblasts Risk Score. | Mediators Inflamm | 2025 | 41498024 | PubTator, text mining | PubMed |
| A Prognostic Neuromodulation-Related Gene Signature Identifies Immunomodulation and Tumour-Associated Hallmarks in Glioblastoma. | Biomedicines | 2025 | 41301734 | PubTator, text mining | PubMed |
| An OSMR-CLIC1 cross talk drives key oncogenic pathways in glioblastoma. | bioRxiv | 2025 | 41279023 | PubTator, text mining | PubMed |
| A multi-omics approach uncovers causality of IL6R on endotypes of subclinical carotid atherosclerosis and the possible role of the IL6R/OSMR pathway. | Cardiovasc Res | 2025 | 41124095 | PubTator, text mining | PubMed |
| Exploring the role of OSMR in gastric cancer: from oncogenic functions to relevant immune features. | Int Immunopharmacol | 2025 | 41110174 | PubTator, text mining | PubMed |
| Role and prognostic value of oncostatin M and its receptor OSMR in acute myeloid leukemia, myeloproliferative neoplasms and non-hematological malignancies. | Front Oncol | 2025 | 41040517 | PubTator, text mining | PubMed |
| Inflammation-Driven Molecular Ageing in Chronic Inflammatory Skin Diseases: Is There a Role for Biologic Therapies? | Cells | 2025 | 41002407 | PubTator, text mining | PubMed |
| An Epigenomic Meta-Analysis of Differentially Methylated Sites in Pre- and Post-Metabolic/Bariatric Surgery Adult Female Patients. | Epigenomes | 2025 | 40981068 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9180/papers?page=3